https://b2idigital.com/adaptimmune-roth
Adaptimmune - Roth Conference Attendee
Adaptimmune is a leader in TCR T-cell therapy, focused on developing novel cancer immunotherapy products. They are a Roth conference attendee featured on B2i...
conference attendeeadaptimmuneroth
https://auctionnews.com/auction/equipnet-inc/cell-gene-therapy-equipment-auction-adaptimmune-therapeutics-uk-lab-closure-phase-iii/12842
Cell & Gene Therapy Equipment Auction - Adaptimmune Therapeutics Lab UK
Bid on over 440 lots of premium laboratory equipment from Adaptimmune Therapeutics Abingdon closure. Ending 21 January 2026. Full details with Auction News
gene therapyequipment auctioncelladaptimmunetherapeutics
https://www.fool.com/investing/2020/05/29/heres-why-adaptimmune-therapeutics-is-rocketing-hi.aspx
Here's Why Adaptimmune Therapeutics Is Rocketing Higher Today | The Motley Fool
May 29, 2020 - Positive results from a handful of patients treated have bolstered confidence in the company's cell-based approach to cancer treatment.
the motley fooladaptimmunetherapeuticshighertoday
https://crueltyfreeinvesting.org/companies/adaptimmune-therapeutics-plc/
Adaptimmune Therapeutics plc - Cruelty Free Investing
Oct 17, 2025 - Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on the provision of cancer immunotherapy products based on its T-cell...
adaptimmune therapeutics plccruelty freeinvesting